Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

YM-11170

Known as: YM 11170, YM11170 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
To determine whether cimetidine increases serum gastrin levels by elevation of intragastric pH or by other mechanisms, the… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2005
2005
Betahistine produced a concentration-dependent contraction of the guinea-pig ileum and was about 27 times less active than… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
1988
1988
A quantitative and rapid method was developed for determination of tissue prostaglandin (PG) levels using reverse phase high… Expand
Is this relevant?
1984
1984
Oral administration of YM-11170 (5-20 mg) inhibited both basal and tetragastrin-induced gastric secretion of acid and pepsin in… Expand
Is this relevant?
1983
1983
MK-208 [3-(((2-(aminoiminomethyl)amino)-4-thiazolyl)-methyl)thio)-N'-(a minosulfonyl) propanimidamide], also known as YM-11170… Expand
Is this relevant?
1983
1983
The effect of 3[[[2-[(diaminomethylene)amino]-4- thiazolyl]methyl]thio]-N2-sulfamoylpropionamidine (YM-11170), a new thiazole H2… Expand
Is this relevant?
1983
1983
The antisecretory property of YM-11170 was compared with that of cimetidine and atropine in the Heidenhain pouch dog. YM-11170… Expand
Is this relevant?
1983
1983
Healing processes of duodenal ulcers induced by mepirizole and effects of several drugs on the ulcer healing were studied in rats… Expand
Is this relevant?
1982
1982
The inhibitory effect of a new H2-receptor antagonist YM-11170 on gastric acid response to histamine and food was compared with… Expand
Is this relevant?
1982
1982
A new H2-blocker, 3-[[[2-[(diaminoethylene)amino]-4-thiazolyl]ethyl]thio]-N2-sulfamoyl propionamidine (YM 11170) inhibited… Expand
Is this relevant?